US-based biopharmaceutical firm Anacor Pharmaceuticals has received a $13.5m research contract from the US Department of Defense, Defense Threat Reduction Agency (DTRA) to design and discover new classes of systemic antibiotics. Research ...
AstraZeneca has partnered with Taiwan’s National Research Program for Biopharmaceuticals (NRPB) in order to support academic research proposals using 'open innovation' as a catalyst for accelerating drug discovery. The project will ...
GlaxoSmithKline (GSK) and Danish biotechnology firm Genmab have filed a supplemental Biologics License Application (sBLA) to the US Food and Drug Administration (FDA) for the use of its leukaemia drug Arzerra (ofatumumab) in combination ...
Tags: GlaxoSmithKline, CLL Patients
Chinese specialty pharmaceutical firm Eddingpharm has received an exclusive, royalty-bearing license from Ablynx to develop and commercialize its anti-RANKL Nanobody, ALX-0141, in China, the Hong Kong and Macao Special Administrative ...
Tags: Eddingpharm, Anti-Rankl Nanobody
Amyris, Inc., a leading renewable chemicals and fuels company, announced that its farnesene plant in Brazil has achieved the production run rate of 1 million liters over a 45-day period. Amyris's Chief Executive Officer John Melo will speak ...
MAX BioPharma has exclusively licensed the small molecule oxysterols from University of California, Los Angeles and Johns Hopkins University in the US. The pharmaceutical company has also received a Small Business Innovation Research ...
Epitaxial deposition and process equipment maker Veeco Instruments Inc of Plainview, NY, USA says that the UK’s University of Nottingham has purchased two GENxplor R&D molecular beam epitaxy (MBE) systems for its School of Physics and ...
Tags: Optoelectronic, Electronics
Veeco Instruments announced that the University of Nottingham, United Kingdom, purchased two GENxplor™ R&D Molecular Beam Epitaxy (MBE) Systems for its School of Physics and Astronomy. The systems will enable the growth of high ...
Tags: MBE Systems, Lighting
One problem in developing more efficient organic LED light bulbs and displays for TVs and phones is that much of the light is polarized in one direction and thus trapped within the LED. University of Utah physicists believe they have solved ...
Fujifilm Corporation and imec have developed a new *photoresist technology for **organic semiconductors that enables the realization of submicron patterns. (For * please see note at bottom for further explanations.) Due to their ...
Tags: Organic Semiconductors, Lighting
US-based biotechnology company X-Chem and UK-based pharmaceutical company AstraZeneca have entered into an expanded global drug discovery collaboration that covers all of AstraZeneca’s therapeutic areas and multiple target classes. ...
Tags: Drug, pharmaceutical
Genia Technologies in consortium with Columbia University and Harvard Medical School, has secured a three-year $5.25m grant from the National Human Genome Research Institute (NHGRI) of the National Institutes of Health (NIH), to develop ...
Tags: Health, Medicine, DNA Sequencing Platform
US-based Quanterix has launched multiplexed single molecule immunoassay technology for improving diagnosis and potential treatment of complex diseases. The multiplexed single molecule immunoassays study, which was partly funded by the ...
US-based DiscoveRx’s BioSeek division launched BioMAP panel, a primary human cell-based assay platform, for oncology research. The BioMAP panel comprising primary human cell-based tumor-host model systems allows the researchers to ...
Tags: Oncology Research, Biomap Panel
The US Food and Drug Administration (FDA) has approved breakthrough therapy designation for Danish biotechnology company Genmab and British pharmaceutical company GlaxoSmithKline’s (GSK) Arzerra (ofatumumab) in combination with ...
Tags: therapy designation, Medicine